SriniVas Sadda, MD

In this Healio Video Perspective, SriniVas R. Sadda, MD, discusses his paper on Nanoscope’s MCO-010 optogenetic therapy in advanced retinitis pigmentosa, which was presented at the Euretina congress in Amsterdam.

In his keynote Euretina Lecture, delivered at the virtual Euretina congress, SriniVas Sadda, MD, highlighted the critical role of the choriocapillaris in age-related macular degeneration.

KOLOA, Hawaii — At Retina 2020, SriniVas Sadda, MD, discusses his daily clinical experience using the Spectralis OCT platform (Heidelberg Engineering).

BALTIMORE – A retrospective analysis of DRCR.net Protocol I data showed patients with persistent edema treated with ranibizumab demonstrated less visual gain in the long-term compared with patients who did not have persistent edema, SriniVas R. Sadda, MD, said at the Association for Research in Vision and Ophthalmology meeting here. This opens the question of whether or not alternative treatment strategies should be discussed earlier in a patient’s care, according to Sadda.

SriniVas R. Sadda, MD, at Retina 2017.

SriniVas Sadda, MD, at Retina 2017.

SriniVas R. Sadda, MD, at Retina 2017.